oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.
![Oragenics logo](/files/LOGO/1174940-OGEN.png)
Company profile
Ticker
OGEN
Exchange
Website
CEO
Alan F. Joslyn
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Noachis Terra Inc. ...
IRS number
593410522
OGEN stock data
Latest filings (excl ownership)
8-K
Other Events
22 Jul 24
8-K
Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
10 Jul 24
8-K
Oragenics, Inc. Announces Proposed Public Offering
26 Jun 24
424B5
Prospectus supplement for primary offering
25 Jun 24
424B5
Prospectus supplement for primary offering
24 Jun 24
8-K
Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
20 Jun 24
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
23 May 24
8-K
Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer
22 May 24
8-K
Other Events
17 May 24
8-K
Other Events
16 May 24
Latest ownership filings
SC 13G
Lind Global Fund II LP
6 Mar 24
SC 13D
Odyssey Health, Inc.
12 Feb 24
5
ROBERT C KOSKI
22 Jan 24
4
J MICHAEL REDMOND
2 Jan 24
3
J MICHAEL REDMOND
2 Jan 24
4
Fred Telling
1 Dec 23
144
Notice of proposed sale of securities
30 Nov 23
4
JOHN P GANDOLFO
6 Oct 23
4
Bruce A. Sr. Cassidy
6 Oct 23
3
JOHN P GANDOLFO
6 Oct 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.07 mm | 2.07 mm | 2.07 mm | 2.07 mm | 2.07 mm | 2.07 mm |
Cash burn (monthly) | 470.50 k | 590.53 k | 820.03 k | 1.71 mm | 1.02 mm | 687.20 k |
Cash used (since last report) | 1.82 mm | 2.28 mm | 3.17 mm | 6.59 mm | 3.95 mm | 2.66 mm |
Cash remaining | 253.03 k | -210.98 k | -1.10 mm | -4.52 mm | -1.88 mm | -584.72 k |
Runway (months of cash) | 0.5 | -0.4 | -1.3 | -2.7 | -1.8 | -0.9 |
Institutional ownership, Q1 2024
33.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 670.00 k |
Total shares | 1.49 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Intracoastal Capital | 1.49 mm | $670.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Dec 23 | J Michael Redmond | Employee Option Common Stock | Grant | Acquire A | No | No | 5.4 | 75,000 | 405.00 k | 75,000 |
30 Nov 23 | Telling Fred | Common Stock | Sell | Dispose S | No | No | 3.5681 | 3,500 | 12.49 k | 38,345 |
8 Aug 23 | Robert C Koski | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 27,940 |
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
5 Jun 24
Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results
22 May 24
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
22 May 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
22 May 24
Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings
22 May 24